Press
Press & Investors
Access our media kit, brand assets, and investor relations information.
Access our media kit, brand assets, and investor relations information.
Official logo — available in multiple formats
EPFL spin-off with proprietary IP and peer-reviewed clinical evidence
CE mark approval and ISO certification demonstrating quality and safety
Addressing multi-billion global market in aesthetic and reconstructive medicine
Growing portfolio of clinical partnerships and published outcomes
Management and advisory board with deep MedTech expertise
Clear roadmap for portfolio expansion and international market entry
Develop additional indications and applications
Scale operations beyond European markets
Collaborate with leading clinics and distribution partners
Continue building robust clinical data and publications
For investors, we provide key figures, pitch decks, and direct IR contacts.
Email: investors@volumina-medical.ch
Contact Investor Relations